Introduction
Cystic �ibrosis (CF) is the most common lethal disease in the Caucausian population. It is caused by mutations in the CFTR gene (OMIM 219700) which encodes a cAMP-regulated Cl -channel that is expressed in the apical plasma membrane of exocrine epithelia [1] . The CFTR protein pool mainly consists of a mannose-rich immature ER (band B) and a complexglycosylated mature isoform (band C) [1] .
Most of our knowledge about the pathology of mutant CFTR protein resides on immunoblot analysis of cell culture [2] [3] [4] [5] [6] [7] [8] [9] [10] . Only few studies examined mutant CFTR in human tissue, i.e. sweat gland [11, 12] , intestine [12] [13] [14] , nasal polyps [12] and lungs [15] . In the context of the upcoming studies on correctors and potentiators of mutant CFTR [16, 17] it is important to enlarge our knowledge about mutant CFTR protein biochemistry. Most individuals with CF carry CFTR gene mutations that give rise to defective or impaired posttranslation processing and/or traf�icking [1, 18, 19] . Even in exocrine pancreassuf�icient patients the delivery of wild-type amounts of mutant CFTR to the apical membrane of epithelial cells is the exception rather than the rule [19] .
The lung is the most af�licted organ in CF and hence is the major target for any novel treatment. To clarify the distribution and abundance of isoforms of normal and mutant CFTR we investigated snap-frozen tissue from freshly explanted non-CF and CF subjects using our protocol that had been established to examine CFTR in rectal biopsies [14] .
Materials and Methods

Tissues and cell lines
Native CF lung epithelium specimens were obtained from freshly explanted CF lungs on the occasion of lung transplantation and snap frozen in liquid nitrogen. Non-CF lung epithelium specimens were analyzed from parts of non-CF donor lung explants that showed regular histology of airway epithelium and submucosal glands. Rectal biopsies were collected with a suction biopsy device from F508del homozygous CF subjects and non-CF healthy volunteers [14] . T84 cells were cultured in DMEM/Ham-F12 medium supplemented with 5% (v/v) fetal calf serum at 37°C in a 5% CO 2 atmosphere.
Antibodies
The following anti-CFTR Abs were used: polyclonal R16 [14] against the N-terminus (aa 1-14, R16/34 or R66/17) and C-terminus (aa 1466-1480, R16/33 or R66/16), the crude antiserum R66, polyclonal R40 [14] against C-terminus (aa 1465-1488), mAb 596 [13] against NBD2 (aa 1204-1211) and mAb 570 [13] against R-domain (aa 731-742). All antibody lots were veri�ied to recognize the B-and C-bands of CFTR in T84 cells.
The following anti-CLCN2 Abs were used: polyclonal anti-CLCN2 Abs C-20 and H-90 (Santa Cruz) and anti-CLCN2 mAb54664 (abcam).
CFTR and CLCN2 immunochemical analyses
The snap frozen specimens (n =8-16) were homogenized at 4°C in the presence of 10 mM iodoacetamide, 61 µg/ml PMSF, 0.35 µg/ml pepstatin and antipain, 1.75 µg/ml leupeptin and aprotonin and 17.5 µg/ml soybean trypsin-inhibitor in Tris-buffer (20 mM Tris/HCl, 150 mM NaCl, pH 8). The lysis started by incubation with 0.03 % SDS for at least 30 min at 4°C, followed by 1 % (v/v) Triton X-100 and 0.5 % (w/ v) sodium deoxycholate for at least 30 min. After centrifugation (16,000×g, 4°C, 20 min) protein contents of the supernatant were determined [20] . Thereafter the supernatant was incubated with the speci�ic preimmune sera and protein A agarose (PAA) for 60 min. Immunoprecipitation (IP) was carried out overnight with the polyclonal antibodies [14] R40 (dilution 1:50 adjusted to volume), R16/33 or R66/16 (1:133, both are against the C-terminus of CFTR) and R16/34 or R66/17 (1:80 against the N-terminus of CFTR) in the presence of protein A agarose and protein G agarose (Santa Cruz Biotechnologies). A second IP was performed overnight with the crude antiserum R66 (1:50) or the polyclonal antibodies C-20 (1:50) and H-90 (1:50). All beads were washed at 4°C twice with 1) PBS with 0.5 % (v/v) Triton X-100 and 0.05 % (w/v) sodium deoxycholate and then twice with 2) 125 mM Tris, 500 mM NaCl, 10 mM EDTA, 0.5 % (v/v) Triton X-100, pH 8. Thereafter the beads were dissolved in 50 µL 3x Laemmli buffer containing dithiothreitol at 37°C for 3 h, then separated by 5% SDS-PAGE (for detection of CFTR) or by 7% SDS-PAGE (for detection of CLCN2) and blotted onto PVDF membranes. CFTR (CLCN2) immunoreactive bands were detected with mAbs 570 and 596 [13, 15] The CFTR/CLCN2-immunoreactive signals were quanti�ied by densitometry of a time series of Hyper�ilms ECL (GE Healthcare) exposed to ECL Advance-covered immunoblots. The density was determined on unsaturated �ilms with exposure times between 10 sec and up to 3 min. For the calculation of the density the average of 5 rectangles in case of the C-band and 3 rectangles in case of the B-band were used to eliminate small inequalities of the densities within the bands. After subtraction of background intensity, all densities were normalized to one minute exposure time. Total protein was determined by the Bradford assay [20] . The density (od/mm 2 ) of all samples was normalized by the amount of total protein. For the calculation of the ratios of C-to B-band the intensities of the complete C-or B-bands were determined (multiplication of the area of the band with the normalized density).
Results
In our standard protocol lung specimens were lysed, the lysate was immunoprecipitated with polyclonal anti-CFTR Abs, and CFTR then visualized by highly speci�ic and sensitive anti-CFTR mAbs on the immunoblot of the PAGE-separated IP. The advantage of an immunoprecipitation followed by a further immunoblot analysis is the enrichment of the target protein and the reduction of the background of false positive bands at the position of the target protein [13] . The speci�icity and sensitivity of this method depends on the availability of polyclonal and monoclonal anti-CFTR antibodies. The used high-af�inity mAbs were developed in the course of recent studies by our peers on F508del homozygotes [13] . The combination of polyclonal anti-CFTR antibodies against the N-and C-terminus of CFTR and the highly sensitive and speci�ic used mAbs led to a high sensitivity of 508del CFTR detection in human rectal biopsies [14] . The protocol has been optimized for high sensitivity. Titrations with variable amounts of the highly CFTR-expressing T84 cells revealed that only 6% of total CFTR was immunoprecipitated from the cell lysates (data not shown) whereas more than 90% of the immunodetectable CFTR was immunoprecipitated from rectal biopsies (Fig. 1) . In all lanes (a-f) the complex-glycosylated C-band and the mannose-rich B-band of CFTR were detectable. Please note the differential glycosylation pattern of band C in rectum and lung. All lanes were taken from different gels. For the correct determination of the size of rectal and lung CFTR, samples from both tissues were run on the same gels. B. Immunoblot analysis of mutant CFTR in lung tissue explanted during lung transplantation. Lysates of non-CF and mutant CF lung specimens were immunoprecipitated with polyclonal anti-CFTR Abs and detected by the anti-CFTR mAbs 570 and 596. In the sample from a non-CF subject (lane a) the strong complex-glycosylated C-band and a weak mannose-rich B-band of CFTR were clearly visible, but in lanes b-f only the mannoserich B-band of mutant CFTR with different mutation genotypes was clearly detectable. All lanes were taken from different gels. Blots were exposed to �ilms for 1 min but samples non-CF5 (10 min), CF3 (20 min), CF5 (10 min) and T84 (10 sec). lungs that had been subject to perioperative histological examination and from the explanted CF lungs that represent end-stage lung disease. All lung specimens of non-CF subjects showed the complex-glycosylated C-band of mature CFTR and a weak, but clearly visible mannoserich B-band of the ER-isoform ( Fig. 2 and 3) . In CF specimens only the mannose-rich isoform of mutant CFTR or no band were detectable ( Fig. 2 and 3B) . No complex-glycosylated mutant CFTR was visible. The preimmune sera (PPI) of the used antibodies for immunoprecipitation did not produce any non-speci�ic by-bands in the sensitive mol.wt. range for CFTR or mutant CFTR detection above 100 kDa (Fig. 2, lanes b, f and g ). Please note the differential glycosylation patterns of the C-band from T84 cells, rectal and lung tissue (Fig. 3 A) . The glycoforms were more disperse in lung than in rectum. In CF lung tissue the mannose-rich B-band was detectable in specimens from six of seven subjects ( Fig. 2 and 3 B) .
For quantitative densitometry blots with low signal intensities were used as shown in Figure 4 for lung samples. Quantitative densitometry revealed that lung tissue contained on the average about �ivefold less CFTR protein than rectal epithelium (Fig. 5) . The ratio of Bto C-band differed considerably in between non-CF lung specimens (Fig. 5) . The detectable amounts of mannose-rich isoform in rectal and lung CF tissues were comparable within the same order of magnitude (Fig. 5) . Rectal suction biopsies and specimens from explanted lung tissue inherently consist of variable proportions of epithelial and non-epithelial cells. To get an estimate of the amount of epithelial cells in the samples, the IPs for CFTR were combined with IPs for CLCN2, a member of the voltage-gated ClC chloride channel family that is expressed in the apical membrane of airway and intestinal epithelium [21, 22] . Hence CLCN2 is a promising candidate for an epithelial marker protein. As shown in Figures 6  and 7 , the proportion of epithelial cells was higher in rectal biopsies than in the examined samples of lung explants.
The majority of F508del homozygous rectal epithelia expressed low amounts of complexglycosylated CFTR [14] . In contrast no band C CFTR was detectable in all investigated CF lung specimens.
Discussion
This study investigated CFTR protein expression in CF lungs at the time of lung transplantation. No mature complex-glycosylated mutant CFTR was detectable at this stage of global respiratory insuf�iciency in subjects with a pancreas-insuf�icient CFTR genotype. The minor ER glycoform, however, was visualized with similar signal intensity on blots of CF and non-CF origin. In other words, the terminal stage of the remodelled and chronically in�lamed CF lungs is characterized by the maintenance of the ER glycoform and the absence of the mature glycoform. If some minute band C was present in the specimen, it was lost during processing below the threshold of detection.
When applying the same immunoblot protocol we previously detected complexglycosylated CFTR in 10 of 12 rectal biopsies taken from F508del homozygotes with mild to moderate CF disease (Fig. 5) [14] . Several reasons probably account for this major difference in the abundance of mutant CFTR in these two types of specimens. First, CFTR was about �ivefold more strongly expressed in the distal intestine than in the majority of examined lungs (see Fig. 5 ; statement applies to all specimens but non-CF2). Second, the intestinal epithelium is turned over every three days, whereas airway epithelium only expands during growth and regenerates after injury. Third, CF lungs are subject to chronic in�lammation, remodelling and dedifferentiation with a concomitant irreversible loss of CFTR-positive epithelial cells [1] . Thus, our immunoblot data on CFTR expression in lungs at the stage of respiratory failure do not allow any de�initive statement on the CFTR protein distribution in native non-injured airways. With the exception of null mutations, some complex-glycosylated [23] [24] [25] .
In conclusion, CFTR immunoblot analysis is feasible with CF lung tissue. This point is relevant in the light of the up-coming clinical trials on CFTR correctors that aim to promote proper processing and targeting of mutant CFTR to and/or to prolong residence time at the apical membrane. However, prior to any implementation of biopsies of respiratory epithelium into a clinical trial, the ex vivo analyses should be repeated with biopsies that had been taken from CF subjects with mild lung disease. CFTR protein analysis should be combined with a histological examination of the specimen to allow a proper interpretation of the immunochemical CFTR data. Moreover, the amount of CFTR should be assigned to the proportion of CFTR-positive epithelia in the examined specimen. Lung tissue is inherently heterogeneous in its composition of epithelial and non-epithelial cells, and the ratio of cell types will vary by specimen. This problem can eventually be reduced by the combination of the determination of protein contents with quantitative immunoblot densitometry of an epithelial marker protein such as CLCN2 [21, 22, 26] .
By the time of writing, however, biopsies from the distal intestine seem to be a more appropriate choice to assess the action of correctors in clinical trials. As already outlined above, the rectal epithelium contains more CFTR protein than respiratory epithelium, shows a rapid turnover, is not subject to pronounced dedifferentiation and remodelling, and �inally and most importantly in the context of a clinical trial, a rectal suction biopsy is safe, painless and repeatable.
